differences in the ExTEM parameters. FibTEM measurements showed a significant difference at the A10 value (13.0 vs. 14.0 mm, P = 0.014) and a trend at the maximum amplitude (maximum clot firmness [MCF] 13 [...] W, Johanning K, Werwitzke S, Trummer A, Bröcker V, Klempnauer J, Winkler M, Tiede A. Recombinant human antithrombin prevents xenogenic activation of hemostasis in a model of pig-to-human kidney transplantation [...] wine, whisk(e)y, or vodka to a target blood alcohol concentration of 1 ‰ within one hour, calculated with the Widmark formula. Blood samples were collected before drinking, at a breath alcohol concentration

Bauersachs J, Haverich A. Eur J Cardiothorac Surg. 2021 Jun 14;59(6):1155-1163. 2. Left Ventricular Assist Devices for Advanced Heart Failure. Schmitto JD, Rojas SV, Haverich A. N Engl J Med. 2017 May [...] ventricular assist device thrombosis. Schmitto JD, Avsar M, Haverich A. N Engl J Med. 2014 Apr 10;370(15):1463-4. 4. Long-term evaluation of a fully magnetically levitated circulatory support device for advanced [...] dieser AG. Ausgewählte Publikationen 1. Five-year outcomes of patients supported with HeartMate 3: a single-centre experience. Schmitto JD, Mariani S, Li T, Dogan G, Hanke JS, Bara C, Pya Y, Zimpfer D

ABC-HCC A Phase IIIb, randomized, multicenter, open-label trial of Atezolizumab plus Bevacizumab versus trans arterial Chemoembolization (TACE) in intermediate-stage HCC Erstlinientherapie ARTEMIDE A Phase [...] Function (Child-Pugh A) after Failure of First-Line Treatment that Included an Anti-PD-(L)1 Compound (GDFATHER-HCC-01) Ösophaguskarzinom/ AEG/ Magen Erstlinientherapie HLX-GC-301 A Randomized, Double-blinded [...] in Patients with advanced Hepatocellular Carcinoma Zweitlinientherapie GDFATHER-HCC-01 (CTL-002-005) A Phase 2b, Randomized, Blinded Trial Investigating the Efficacy and Safety of Visugromab in combination

Germany: a qualitative interview study”. BMC Health Services Research 26, 710. https://doi.org/10.1186/s12913-026-14728-3 Segawa, S., Alpinar-Segawa, Z . (2026). "How can we foster solidarity in a culturally [...] online on January 31, 2015. doi: 10.1007/s11019-015-9623-z Alpinar-Sencan, Z. (2014). “A Social Understanding of Dignity: A Promising Approach in the Organ Selling Debate.” Bioethica Forum. 7(4): 148–54. Alpinar [...] M. Ramšak, P. Łuków, A. Muzur, F. Steger (eds.). Applied Ethics – Medicine Series . Freiburg: Karl Alber Verlag, 155-77. Alpinar-Sencan, Z. (2021). “Selling Organs: Dignity as a Further Concern”. In:

it is estimated that a total of 27 to 36 million people suffer from a rare disease in Europe. Typically, rare diseases manifest early in life, sending children and their parents on a diagnostic odyssey for [...] actinopathies, genetic alterations are associated with a wide range of clinical manifestations. Although patients are diagnosed with the same disorder, only a subset exhibit specific symptoms. The underlying [...] rare diseases are caused by genetic alterations, making genetic testing the most promising tool for a fast and accurate diagnosis. The integrated use of third-generation sequencing techniques allows us

Mitarbeiter der AG Lochner Wichtigste Publikationen: Beckstette M, C Lu, S Herppich, EC Diem, A Ntalli, A Ochel, F Kruse F, B Pietzsch, K Neumann, J Huehn, S Floess, M Lochner. 2022. Profiling of epigenetic [...] Fohse, I Prinz, J Pezoldt, S Suerbaum, T Sparwasser, A Hamann, S Floess, J Huehn, M Lochner. 2016. Foxp3(+) T cells expressing RORgammat represent a stable regulatory T-cell effector lineage with enhanced [...] Regulatory T cells promote a protective Th17-associated immune response to intestinal bacterial infection with C. rodentium . Mucosal Immunol. 7(6):1290-1301. Berod, L, C Friedrich, A Nandan, J Freitag, S Hagemann

N. Exploring status and demand for palliative day-care clinics and day hospices in Germany: A protocol for a mixed-methods study. BMC Palliat Care 2021;20:94 (BMC Palliat Care) Huperz C, Apolinarski B [...] Untersuchung mittels Fokusgruppen und Interviews. Z Palliativmed. 2024. DOI: 10.1055/a-2286-1262 (Z Palliativmed) Stiel S, Ernst A, Apolinarski B, Röwer HAA, de Jong L, Burger B, Schütte S, Schneider N, Damm K [...] expansion of palliative day care clinics in Germany: Results of a Delphi study. BMC Palliat Care 2024;23:116 (BMC Palliat Care) Stiel S, Ernst A, Röwer HAA, de Jong L, Burger B, Schneider N, Damm K, Stahmeyer

Beispiel für Literaturverzeichnis Journal / Zeitschrift Zormpas, C., Silber-Peest, A.S., Eiringhaus, J., Hillmann, H.A.K., Hohmann, S., Müller-Leisse, J., Westhoff-Bleck, M., Veltmann, C., and Duncker, [...] 1002/ehf2.13467. Zou, C., El Dika, I., Vercauteren, K.O.A., Capanu, M., Chou, J., Shia, J., Pilet, J., Quirk, C., Lalazar, G., Andrus, L., Kabbani, M., Yaqubie, A., Khalil, D., Mergoub, T., Chiriboga, L., Rice [...] und erweiterte Auflage, Egger, M., Razum, O., Rieder, A., and Habermann-Horstmeier, L. eds., (Berlin, Boston: De Gruyter) pp. 99-112. Zawinell, A., and Seifert, R. (2021). Antiallergika. In: Arzneiver

medical care Donabedian, A. Betriebswirtschaft und Management im Krankenhaus Haubrock, M. Buchführung und Jahresabschluss in Krankenhäusern / Hentze, J. To err is human. Building a safer health system Kohn [...] J. Logistic Regression. A Self-Learning Text Kleinbaum, D.G. An Introduction to Survival Analysis Using Stata Cleves, M. Discovering Statistics using IMB SPSS Statistics Field, A. Routinedaten im Gesun [...] Health: Gesundheit und Gesundheitswesen Schwartz, F.W. Rose’s Strategy of Preventive Medicine Rose, G.A. Referenzwerk Prävention und Gesundheitsförderung – Grundlagen, Konzepte und Umsetzungsstrategien Hurrelmann

M-L u.v.a. (2021). Die Neustart! Zukunftsagenda – für Gesundheit, Partizipation und Gemeinwohl. Robert Bosch Stiftung, Stuttgart. Klawunn R , Walzer S, Zerth J, Heimann-Steinert A, Schepputat A, Forster [...] Staude H, Taylan C, Thumfart J, Weitz M, Ringlstetter R, Großhennig A & Pape L (2025). Results of a multicenter, randomized trial examining a new transition model for post-kidney transplant adolescents. Sci [...] digital workplace-based health promotion: a pilot study for office workers. Front. Public Health 13:1437172. doi: 10.3389/fpubh.2025.1437172 Seidel G, Bornemann A, Meyer A, Kretschmer J, Krug J, Dierks M-L (2025)